doi: 10.1161/CIRCULATIONAHA.105.592410
(Circulation. 2007;115:534-545.)
© 2007 American Heart Association, Inc.
Congenital Heart Disease for the Adult Cardiologist |
Arrhythmias in Adult Patients With Congenital Heart Disease
From the Electrophysiology Division, Department of Cardiology, Children’s Hospital Boston, and Department of Pediatrics, Harvard Medical School, Boston, Mass.
Correspondence to Edward P. Walsh, MD, Cardiac Electrophysiology, Children’s Hospital Boston, 300 Longwood Ave, Boston MA 02115. E-mail epwalsh{at}cardio.tch.harvard.edu
Key Words: ablation • atrial flutter • heart defects, congenital • arrhythmia • pacemakers • electrophysiology • pediatrics
 |
Introduction |
|---|
 Top Introduction PrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
By the time patients with congenital heart disease (CHD) reach adolescence and early adulthood, rhythm status has often become an active issue, if not the central issue, in their cardiac management. For some, arrhythmias are intrinsic to the structural malformation itself, as is the case with Wolff-Parkinson-White syndrome in the setting of Ebstein’s anomaly, or atrioventricular (AV) block in the setting of "congenitally corrected" transposition of the great arteries (L-TGA). For most other CHD patients, arrhythmias represent an acquired condition related to the unique myocardial substrate created by surgical scars in conjunction with cyanosis and abnormal pressure/volume loads of long duration. This review will attempt to address the major rhythm difficulties faced by adults with CHD, concentrating on electrophysiological features that distinguish CHD from more conventional forms of adult heart disease. A listing of specific arrhythmias and commonly associated congenital defects is provided in Table 1 to serve as an outline for the discussion.
|
|
Prevalence |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
As of 2001, there were estimated to be 800 000 adults with CHD living in the United States,1 a number that has grown steadily as more survivors of childhood surgery reach maturity. Of these, roughly 45% are considered to have mild forms of CHD (eg, atrial septal defect, valvar pulmonary stenosis), 40% are classified as having moderate disease (eg, tetralogy of Fallot, Ebstein’s anomaly), and 15% are considered to have complex disease (eg, single ventricle, transposition of the great arteries). Although arrhythmias can develop within any of the 3 subgroups, the incidence is highest for patients in the moderate and severe categories. Tetralogy of Fallot is an instructive example of moderate CHD with a large arrhythmia burden. As many as one third of patients with repaired tetralogy develop symptomatic atrial tachycardias by adulthood,2
10% develop high-grade ventricular arrhythmias,3 and 5% require pacemaker implantation for surgically acquired AV block or sinus node dysfunction.4 In addition, a small but increasing number are now receiving implantable cardioverter defibrillators (ICDs) for treatment of ventricular tachyarrhythmias.5 Clearly, serious arrhythmias develop in a sizable segment of the population with repaired tetralogy, all of which contribute to a sudden death risk that is currently measured at 2% per decade of follow-up.6 Even when using conservative population assumptions, this translates on a national level to more than 50 000 adult patients with tetralogy who require close electrophysiological attention, and perhaps as many as 100 sudden arrhythmic deaths per year if patients were left untreated. Although the magnitude of this sudden death risk may seem small compared with the threat faced by older patients with ischemic heart disease, the emotional impact of unexpected death in a young adult who has struggled with CHD throughout his or her abbreviated lifetime is nonetheless profound. The situation is equally concerning for patients falling into the category of severe CHD. The Fontan operation for single ventricle, as well as the atrial switch operations (Mustard or Senning) for transposition of the great arteries, results in extensive suture lines and abnormal hemodynamics that predispose patients to atrial tachycardias and sinus node dysfunction. Up to 50% of patients with single ventricle who have undergone older-style Fontan operations will develop atrial tachycardia within a decade of surgery,7 and hardly any transposition patients remain in reliable sinus rhythm 10 years after Mustard or Senning repairs.8 These patients pose challenges in terms of both rhythm control9 and prevention of thromboembolic complications.10 Any center with a sizable adult CHD program is now likely to be involved with ongoing care for hundreds of such cases.
The rhythm prognosis for older CHD patients is sobering, but in some ways, it might be viewed as an indirect triumph for pediatric cardiology and cardiac surgery. Patients who in past years would have perished during infancy are now surviving thanks to accurate anatomic diagnosis and early surgical intervention. Late-onset arrhythmias in adulthood appear to have become the price to pay for decades of effective hemodynamic palliation, and fortunately, treatment options for the arrhythmias themselves are improving rapidly to meet the emerging demand. Perhaps the most optimistic facet of the arrhythmia experience in CHD involves modern refinements in surgical strategy that have arisen in response to dissatisfaction with earlier electrophysiological outcomes. Nowadays, transposition is managed with direct arterial switch rather than large atrial baffles, Fontan connections are constructed in such a way as to minimize right atrial dilation, and tetralogy of Fallot is being repaired at younger ages with smaller right ventricular (RV) incisions and attempts to preserve competence of the pulmonary valve. Modifications of this sort have resulted in a promising reduction in the incidence of late arrhythmias11–14 for the younger generation of CHD patients.
|
Tachycardias in Adults With CHD |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
Accessory Pathways and Twin AV Nodes
The embryological accidents responsible for congenital heart defects can have a direct impact on development of the conduction system. Sometimes this takes the form of simple displacement of the AV node and His bundle away from the usual septal position in Koch’s triangle,15 but occasionally, the malformation results in accessory or duplicated AV connections with the potential for reentrant tachyarrhythmias. The most familiar example involves Ebstein’s anomaly of the tricuspid valve, which is complicated by Wolff-Parkinson-White syndrome in
20% of cases.16 The accessory pathways in Ebstein’s anomaly are typically located along the posterior and septal aspect of the tricuspid ring where the valve leaflets are most abnormal,17 and nearly half of these patients will be found to have multiple accessory pathways.18,19 The same observations hold true for patients with L-TGA, who not infrequently have Ebstein’s malformation in association with accessory pathways along their left-sided tricuspid valve. Tachycardia events for Ebstein’s patients become increasingly problematic in adolescent and adult years when atrial dilation increases the likelihood of recurrent atrial flutter or atrial fibrillation with potentially rapid anterograde conduction over the accessory pathway(s). Definitive therapy with catheter ablation is now viewed as the standard of care for Ebstein’s patients with Wolff-Parkinson-White syndrome. However, compared with ablation for simple accessory pathways in a structurally normal heart, it must be recognized that the short-term success rate appears lower, and the risk of recurrence higher, in Ebstein’s anomaly.20,21 These differences result from the challenges of distorted anatomic landmarks, difficulty identifying the true AV groove,22 extremely fractionated electrograms, and the high incidence of multiple pathways.
A more exotic type of redundant AV connection can occasionally be identified in patients with a single ventricle of the heterotaxy variety, when there is a specific combination of anatomic defects involving discordant AV alignment and a large septal defect in the AV canal region. In this situation, patients can actually have 2 separate AV nodes (so-called twin AV nodes) with 2 discrete His bundles,23 often with evidence of a connecting fiber24 between these 2 systems (so-called Mönckeberg sling). A wide variety of reentrant tachycardias can arise within this complicated network (Figure 1), most of which can be eliminated by strategic ablation of 1 limb of the duplicated system.25,26 Although twin AV nodes are very rare, the condition epitomizes the peculiar conduction arrangements that are possible in CHD.
|
Intra-Atrial Reentrant Tachycardia (Atrial Flutter)
The most common mechanism for symptomatic tachycardia in the adult CHD population is macroreentry within atrial muscle.27 The terms "intra-atrial reentrant tachycardia" (IART) and "incisional tachycardia" have become customary labels for this arrhythmia in order to distinguish it from the typical variety of atrial flutter that occurs in structurally normal hearts.28–30 Generally, IART tends to be slower than typical flutter, with atrial rates in the range of 150 to 250 per minute. In the setting of a healthy AV node, such rates will frequently conduct in a rapid 1:1 A:V pattern that can result in hypotension, syncope, or possibly cardiac arrest.9,31 Even if the ventricular response rate is safely titrated, sustained IART can cause debilitating symptoms in some patients from loss of AV synchrony and may contribute to thromboembolic complications10 when the duration is protracted.
Usually, IART appears many years after operations that involved an atriotomy or other surgical manipulation of right atrial tissue. It can follow simple procedures such as closure of an atrial septal defect on occasion, but the incidence is highest among patients with advanced dilation, thickening, and scarring of their right atrium.32,33 Other risk factors for IART include concomitant sinus node dysfunction (tachy-brady syndrome) and older age at time of heart surgery.7 Hence, IART is especially problematic for older patients who have undergone the Mustard, Senning, or older-style Fontan operations, in which extensive suture lines and long-term hemodynamic stress result in markedly abnormal atrial myocardium.
The route of propagation for an IART circuit varies according to the anatomic defect and type of surgical repair.34 It is usually restricted to right atrial tissue (regardless of the surgical destination of this tissue) and is modulated by regions of fibrosis from suture lines or patches, which function in combination with natural conduction barriers (crista terminalis, valve orifices, and the superior and inferior caval orifices) to channel the wave front along a macroreentrant loop.35,36 If a tricuspid valve is present, the isthmus between the valve ring and the inferior vena cava is a common component of such circuits, but when the tricuspid valve is absent or otherwise deformed, the circuits follow less predictable paths that can only be deciphered by formal electrophysiological mapping (Figure 2). Quite often, multiple IART circuits can be present in the same patient.37
|
The clinical diagnosis of IART can usually be made from the standard ECG. Uninitiated clinicians may occasionally misinterpret IART with 2:1 or 3:1 conduction as sinus rhythm if atrial activity happens to be obscured by the QRS and T-wave (Figure 3). The index of suspicion for IART should always be high in older CHD patients; if there is ever uncertainty about the underlying rhythm, vagal maneuvers ought to be performed in an effort to uncover hidden P waves. Once recognized, IART can be reliably terminated with electrical cardioversion, overdrive pacing maneuvers,38 or administration of certain class I or class III antiarrhythmic drugs. The far more difficult task is prevention of recurrence. Multiple strategies have been developed for IART prevention, all of which can have value in selected patients, but none of which represents the universal solution. If the episodes are infrequent, well tolerated, and recognized promptly, it may be sufficient to rely on periodic cardioversion before embarking on more involved therapy. However, if IART episodes become frequent, cause significant symptoms, or are associated with atrial thrombus formation, aggressive treatment is indicated.
|
The therapeutic options for IART include (1) antiarrhythmic drugs, (2) pacemaker implantation to correct bradycardia and/or provide automatic atrial antitachycardia pacing, (3) catheter ablation, and (4) surgical intervention with a modified atrial maze operation. The choice must be tailored to the hemodynamic and electrophysiological status of the individual patient. Chronic antiarrhythmic drugs are still prescribed in some cases, but the broad experience with pharmacological therapy for this condition has been discouraging,9,39 even when potent agents such as amiodarone are used. Pacemaker implantation may be reasonable for patients with a picture of tachy-brady syndrome, because correcting slow atrial rates to the physiological range often results in reduction of IART frequency.31 Pacemakers with advanced programming features that incorporate atrial tachycardia detection and automatic burst pacing to interrupt reentry may also be beneficial in select cases.31,40
Catheter ablation is now used at many centers as an early intervention for IART.41 The technique has evolved rapidly since the introduction of 3D mapping for improved circuit localization28,35,37,42 and irrigated-tip or large-tip ablation catheters for more effective lesion creation.42–44 When these technologies are combined with good anatomic definition and traditional electrophysiological mapping maneuvers, short-term success rates of nearly 90% can be achieved. Unfortunately, later tachycardia recurrence is still disappointingly common. The recurrence risk is particularly high (nearly 40%) among Fontan patients, who tend to have the largest number of IART circuits and the thickest/largest atrial dimensions. Although far from perfect, ablation outcomes for IART are likely to improve with continued experience and even now are far superior to the degree of control obtained with medications alone. Furthermore, even if IART episodes are not eliminated entirely by ablation, the procedure can often provide substantial improvement by reducing the frequency of episodes and eliminating the need for ongoing drug therapy.42
If the above measures fail to prevent IART, or if the patient is returning to the operating room for hemodynamic reasons, consideration should be given to surgical ablation during a right atrial maze operation. This procedure is used most often for the Fontan population with the most refractory variety of IART and is usually combined with revision of the Fontan connection from an older atriopulmonary anastomosis to a modern cavopulmonary connection in the same setting.45 Results are encouraging, with relatively low rates of IART recurrence (12%), but surgical risks must be weighed against the electrophysiological benefit. A prospective trial aimed at comparing various IART management options would be welcome, particularly one that could address the much debated issue of catheter ablation versus surgical maze in Fontan patients.42,45
Atrial Fibrillation
The principle hemodynamic derangement and site of surgical scarring in CHD tends to involve right heart structures, so that IART arising from the right atrium is far and away the most common form of atrial tachycardia. However, chronic hemodynamic stress is directed toward the left atrium in a subset of CHD patients, and atrial fibrillation may occur as a result. The CHD lesions commonly associated with atrial fibrillation include aortic stenosis, mitral valve deformities, and unrepaired single ventricle.46 Management principles are similar to atrial fibrillation encountered in other forms of adult heart disease, beginning with medical therapy for anticoagulation and ventricular rate control, followed by electrical or medical cardioversion. As with IART, terminating an isolated atrial fibrillation episode in CHD is not difficult, but prevention of recurrence remains a challenge. Antiarrhythmic drugs may offer long-term protection against recurrence for some patients, but like IART, pharmacological therapy has been only marginally successful for this purpose. Pacemaker implantation may reduce atrial fibrillation recurrences in patients with sinus node dysfunction when fibrillation is part of the tachy-brady syndrome. Definitive elimination of atrial fibrillation can be achieved with a combined right and left atrial maze operation, which should be considered if a patient requires surgery to address other hemodynamic issues.47 To the best of our knowledge, catheter ablation has not yet been reported for atrial fibrillation in the setting of CHD.
Ventricular Tachycardia
Serious ventricular arrhythmias are rare among CHD patients during their first decade or 2 of life, but once adulthood is reached, the potential for ventricular tachycardia (VT) and sudden death becomes a looming concern in select cases. Patients at greatest risk for developing VT appear to be those who have undergone a ventriculotomy and/or patching for certain types of ventricular septal defects. In this scenario, the mechanism for VT is reminiscent of the macroreentrant circuits described earlier for IART, involving narrow conduction corridors defined by regions of surgical scar48,49 in conjunction with natural conduction barriers such as the rim of a septal defect or edge of a valve annulus (Figure 4). Less commonly, ventricular arrhythmias can develop independently of direct surgical scarring whenever a long-standing hemodynamic overload causes advanced degrees of ventricle dysfunction or hypertrophy. Examples of CHD lesions that can eventually lead to this myopathic variety of VT include (1) aortic valve disease,50,51 (2) L-TGA when the RV has been recruited as the systemic ventricle,52 (3) severe Ebstein’s anomaly, (4) certain forms of single ventricle, (5) Eisenmenger’s syndrome, and (6) unrepaired tetralogy of Fallot.53
|
The bulk of literature and clinical experience regarding VT in CHD has centered on tetralogy of Fallot. The prevalence of VT after tetralogy repair has been estimated to be between 3% and 14% in several large clinical series.2,3,6,54–56 Some patients with slow VT may be hemodynamically stable at presentation, but VT tends to be rapid for the majority, causing syncope or cardiac arrest as the presenting symptom. Even though rare cases of abrupt AV block or rapidly conducted IART have been linked to catastrophic outcomes in tetralogy,57 sustained VT appears to be the single biggest contributor to the 2% per decade incidence of sudden cardiac death (Table 2).6,55,58–60
|
Predicting VT events in tetralogy patients has been a topic of intense investigation for nearly 30 years. Selected articles from the long list of studies* seeking risk factors are summarized in Table 3. To date, no perfect risk-stratification scheme has emerged, although several clinical variables with modest prognostic value have been identified, including (1) older age at time of definitive surgery, (2) history of palliative shunts, (3) high-grade ventricular ectopy, (4) inducible VT at electrophysiological study, (5) abnormal RV hemodynamics, and (6) wide QRS width (>180 ms). The recently appreciated correlation between QRS duration and VT54,55 is not surprising when one considers that the most dramatic degree of QRS prolongation tends to be seen among tetralogy patients with highly dysfunctional and dilated RVs (so-called mechanoelectric interaction). When viewed in the aggregate, this long list of variables helps to define a clinical profile for the tetralogy patient at risk, but no single item can be viewed as completely independent, and none provides perfect predictive accuracy.
|
If this generalized high-risk profile were applied to any contemporary population of adult tetralogy patients, the number who fit the mold could be impossibly large. To compensate for lack of specificity, the practical approach to VT risk stratification in older tetralogy patients usually incorporates attention to symptom status. Obviously, any patient who has survived a cardiac arrest or sustained VT is treated aggressively, usually with an ICD.5,82 But, in the absence of a serious clinical event, careful inquiry for more subtle symptoms is often relied on to determine whether additional testing or treatment is needed. At most centers, tetralogy patients who report concerning symptoms of palpitations, dizziness, or syncope usually undergo invasive evaluation with hemodynamic catheterization and electrophysiology study. Programmed ventricular stimulation provides reasonably good predictive information on the risk of future clinical VT events.83,85 A positive study may prompt implantation of a primary prevention ICD,5 or if monomorphic VT can be induced and is tolerated long enough to permit mapping, catheter ablation of the VT circuit might be considered.86–89 An electrophysiology study might also uncover IART as a contributing or confounding factor for a patient’s symptoms, which could be addressed with ablation at the same setting. Correctable hemodynamic issues may also be identified at catheterization that could shift therapy toward a surgical solution, such as relief of valve regurgitation combined with formal intraoperative VT mapping and ablation.79
The proper approach to an entirely asymptomatic adult with repaired tetralogy remains unsettled. Most clinicians rely on a yearly evaluation with history and ECG, supplemented regularly with Holter monitoring or exercise testing to screen for high-grade ventricular ectopy, along with periodic echocardiography or magnetic resonance imaging to monitor the status of the RV. Should nonsustained VT be detected on surveillance monitoring in an asymptomatic patient, or should RV function appear to be deteriorating, opinions still vary widely as to the appropriate response. Some clinicians would advocate electrophysiology study to refine the arrhythmia risk, some would recommend surgery for pulmonary valve replacement, some would prescribe antiarrhythmic drugs, some would implant a primary prevention ICD, and some might refrain from any treatment as long as the patient remains symptom free. Therapy continues to be individualized for asymptomatic patients depending largely on institutional experience and philosophy.
The lack of objective guidelines for VT prediction and treatment in CHD patients is frustrating, but it would be hazardous to adopt a dogmatic stance based on the data at hand. With few exceptions,55,83 studies have been limited to single-center investigations with limited statistical power. Furthermore, because the event rate for sustained VT and sudden death in CHD is low compared with conditions such as ischemic heart disease, the duration of prospective follow-up necessary to answer questions in the CHD field would likely have to extend beyond 10 years. Now that the population of adults with CHD at risk for VT has reached such a substantial size, the opportunity may finally have arrived for an organized assessment of VT management. The ideal design for investigations of this type must involve close collaboration between pediatric and adult CHD programs to ensure continuity of data collection. It is incumbent on interested clinicians to design and cooperate in long-term multicenter studies of these arrhythmias.
|
Bradycardias in Adults With CHD |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
Sinoatrial Node Dysfunction in CHD
Developmental defects involving the caval-atrial junction can be associated with atypical anatomy and function for the sinoatrial node. This issue is most relevant to complex forms of heterotaxy syndrome in patients with a single ventricle. In the asplenia variety of heterotaxy, bilateral superior caval veins often exist, each with its own sinoatrial node, which results in an interesting ECG pattern of fluctuation between 2 discrete P waves at physiological rates. Apart from the unusual ECG, the coexistence of 2 sinus nodes is of minimal clinical consequence. In contrast, patients with the polysplenia type of heterotaxy may lack a true sinus node altogether, which makes atrial depolarization dependent on slower atrial or junctional escape rhythms.90 Most patients with this rare condition will ultimately require pacemaker implantation.
A more common cause of sinus bradycardia in adults with CHD is surgical trauma to the sinoatrial node or its artery, as may occur during the Mustard, Senning, Glenn, and Fontan operations.7,8,27,91 Chronotropic incompetence is poorly tolerated in CHD patients with compromised hemodynamics, especially those with a single ventricle or AV valve regurgitation. The likelihood of a patient developing IART or atrial fibrillation is also increased significantly in this setting.7
Implantation of an AAIR or DDDR pacing system is currently recommended92 as a class I indication for any patient with CHD and sinoatrial node dysfunction who has symptoms directly attributable to slow heart rate. Pacemaker implantation is also advised as a class IIb indication for CHD patients with resting rates of <40 bpm or sinus pauses in excess of 3 seconds, even in the absence of symptoms. As will be discussed, decisions regarding device implantation cannot be made casually in CHD patients because of the need for epicardial implants and distorted venous pathways in many cases.
AV Block in CHD
The AV conduction tissues may be congenitally abnormal in terms of both their location and function in specific forms of CHD, most notably L-TGA and endocardial cushion defects.93–95 In the former condition, the AV node and His bundle are displaced in an anterior direction away from the usual position in Koch’s triangle, whereas in the latter, the AV node and His bundle are displaced posterior to Koch’s triangle. The functional properties of these displaced conduction systems are often abnormal. In L-TGA, it is estimated that 3% to 5% of patients will have complete AV block at birth, and an additional 20% will develop spontaneous complete block by adulthood.96,97 Even when intrinsic conduction appears normal, these patients appear to be more susceptible to traumatic AV block during surgical or catheter procedures.
Surgical repair of certain forms of CHD can result in direct trauma to the AV conduction tissues. Although improved knowledge of the precise location for the AV node and His bundle in various forms of CHD15,94,95,98 has reduced the occurrence, closure of some ventricular septal defects, surgery for left-heart outflow obstruction, and replacement or repair of an AV valve may still be complicated by AV block. Fortunately, in more than half of cases, this injury is a transient affair related to myocardial stretch or edema rather than physical severing of the conduction tissues, and AV conduction recovers within 7 to 10 days of operation.4 But, for any patient with postoperative AV block that is not expected to resolve or that persists at least 7 days after cardiac surgery, permanent pacemaker implantation is advised92 as a class I indication. A pacemaker may be considered by some as a class IIb indication when surgical AV block recovers but the patient is left with permanent bifascicular block.57
|
Pacemaker and ICD Implantation in Adults With CHD |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
Indications
An important consideration when one interprets the American College of Cardiology/American Heart Association/North American Society of Pacing and Electrophysiology task force guidelines for pacemaker implantation92 is that standard transvenous systems may be contraindicated or difficult in many CHD patients owing to complexities of venous anatomy or to the presence of significant intracardiac shunting that creates a thromboembolic risk from intravascular leads. Epicardial implantation is certainly possible in these circumstances, although the surgery is more involved, and long-term lead performance may be inferior to transvenous systems. Additionally, epicardial lead placement in an older CHD patient who has undergone multiple prior cardiac operations presents the surgeon with a highly scarred mediastinum; dissection down to the myocardial surface must be performed carefully and deliberately to uncover sites with good sensing and pacing function. If a CHD patient is undergoing cardiac surgery for other hemodynamic reasons and it appears highly likely that epicardial pacing might be needed at some distant date, the surgeon may want to take advantage of wide intraoperative exposure to place leads for future use. Fortunately, 86% of leads placed at the time of cardiac surgery are found to function well when retrieved at a mean of 252 days after the operation.99
The indications for ICD implantation in CHD patients are still evolving, but in general, they follow guidelines that are similar to other varieties of adult heart disease. The most common type of CHD that requires ICD implantation is tetralogy of Fallot, followed by transposition of the great arteries and left-sided obstructive diseases.5,85,100
The experience with biventricular resynchronization pacing in CHD patients with depressed ventricular function is limited but promising.101 Clinical studies are now under way to refine selection criteria, as well as to investigate the clinical merits of RV resynchronization to offset right bundle-branch block after surgical closure of ventricular septal defects and tetralogy repair.
Technical Considerations
Careful preprocedural planning is essential for successful pacemaker or ICD implantation in adults with CHD (Table 4). Some of these patients can have anomalies of systemic venous return and the coronary veins, the most common of which is persistent left superior vena cava draining to the coronary sinus.102 In this situation, the right superior vena cava and innominate vein can vary in size from normal caliber to completely absent. Implantation is still possible through a left superior vena cava, although making the necessary turn across the tricuspid valve from the coronary sinus is difficult and may require use of a long sheath or a large right atrial loop to direct the tip toward the ventricle.103 If pacing within the coronary sinus is needed for cardiac resynchronization or any other purpose, anomalies of the coronary sinus need to be considered, including ostial atresia,104 unroofed coronary sinus, and extreme dilation due to persistent left superior vena cava.
|
Venous occlusion is a recognized complication of permanent transvenous pacing leads.105,106 Risk factors for venous thrombosis after lead placement include the absence of anticoagulant therapy, a history of prior venous thrombosis, use of female hormone therapy, and the presence of multiple pacing leads.107 Venous occlusion is therefore common in adult CHD patients with long-term pacing who may have multiple leads in place for several decades. A contrast injection into the antecubital vein(s) with follow-through venography is helpful to investigate acquired and congenital abnormalities. If venous access is needed in the setting of a complete venous occlusion, a variety of techniques for recanalization and venous dilation are now available.108
Transvenous chamber access can be an issue if complicated atrial baffling has been used to redirect venous return. One major challenge in this regard occurs when ventricular pacing is needed after a Fontan repair. An epicardial approach is used in most of these cases, but successful transvenous ventricular lead implantation after the Fontan operation has now been reported in several series, usually involving lead placement into a coronary venous branch vessel.109–112
Combined challenges of surgical obstacles, chamber access, and unusual ventricular geometry are present in patients with transposition of the great arteries after an atrial switch (Mustard or Senning) procedure.113 Extensive atrial baffling limits sites of atrial capture to small regions in the left atrial appendage (where phrenic nerve stimulation may be hard to avoid), anterior left atrial roof, or superior cava–right atrial junction. Baffle obstruction is fairly common in these patients and may require endovascular stent placement before lead placement (Figure 5). In addition, the ventricular lead must be placed in a morphological left ventricle that is thin and nontrabeculated, which requires close attention to tip fixation and sensing parameters.
|
Intracardiac shunts can lead to embolic stroke via right-to-left shunting or inadvertent lead placement in the systemic circulation.114 These shunts can occur at either the atrial or ventricular level, ranging from a patent foramen ovale to large residual septal defects and patch leaks. In addition, patients with high central venous pressure (as often occurs after the Fontan repair) can develop direct connections between the supracardiac veins and pulmonary venous atrium through veno-venous collaterals.115,116 Trivial shunts that are predominately left-to-right are probably not absolute contraindications to transvenous leads, but larger shunts, particularly if right-to-left, need to be evaluated carefully by angiography or echocardiography before a final decision is made on the route for lead implantation. If transvenous leads are strongly preferred in such cases, shunt closure can be attempted beforehand with interventional techniques such as septal occluders, covered stents, or even surgery.117,118 If intracardiac shunting cannot be eliminated satisfactorily, epicardial lead placement is probably the wisest alternative. If there are still compelling indications for a transvenous system, anticoagulation is used after lead placement in patients with residual shunting at most centers, although no firm data currently exist to verify the efficacy of this measure.
Transvenous ICD lead implantation requires a thorough understanding of the ventricular anatomy and chamber positions to anchor the lead tip securely and ensure a suitable vector for defibrillation. When epicardial ICD leads are required, there has been a shift away from traditional patches to novel configurations involving coils (Figure 6) placed in a subcutaneous or pericardial position.119 The experience with this approach is limited, but it appears to offer increased flexibility that can accommodate a wide variety of ventricular geometries and heart sizes.
|
|
Conclusions |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
Arrhythmias in adults with CHD are a growing problem that requires unique solutions. The number of clinicians trained to provide electrophysiological care to this unusual patient group is still somewhat limited. Cardiology and electrophysiology training programs need to consider devoting more curriculum time to this topic in an effort to improve care delivery into the future. The paucity of evidence-based management protocols for arrhythmias in adults with CHD is also a concern, and a need clearly exists for larger collaborative studies involving both pediatric and adult CHD centers to generate more objective treatment guidelines.
|
Acknowledgments |
|---|
Disclosures
None.
|
Footnotes |
|---|
*References 2, 3, 6, 14, 48, 49, 54–58, and 61–84.
|
References |
|---|
|
TopIntroductionPrevalenceTachycardias in Adults With...Bradycardias in Adults With...Pacemaker and ICD Implantation...ConclusionsReferences |
|---|
1. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001; 37: 1170–1175.
2. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot: correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995; 91: 2214–2219.
3. Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD, Downer E, McLaughlin PR, Williams WG. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997; 30: 1368–1373.[Abstract]
4. Weindling SN, Gamble WJ, Mayer JE, Walsh EP. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998; 82: 525–527.[CrossRef][Medline] [Order article via Infotrieve]
5. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004; 15: 72–76.[Medline] [Order article via Infotrieve]
6. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329: 593–599.
7. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer JE, Walsh EP. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997; 113: 80–86.
8. Flinn CJ, Wolff GS, Dick M, Campbell RM, Borkat G, Casta A, Hordof A, Hougen TJ, Kavey RE, Kugler J. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med. 1984; 3310: 1635–1638.
9. Garson A, Bink-Boelkens MTE, Hesslein PS, Hordof AJ, Keane JF, Neches WH, Porter CJ. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985; 6: 871–878.[Abstract]
10. Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol. 1994; 24: 1365–1370.[Abstract]
11. Rhodes LA, Wernovsky G, Keane JF, Mayer JE, Shuren A, Dindy C, Colan SD, Walsh EP. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thor Cardiovasc Surg. 1995; 109: 303–310.
12. Cecchin F, Johnsrude CL, Perry JC, Friedman RA. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol. 1995; 76: 386–391.[CrossRef][Medline] [Order article via Infotrieve]
13. Stamm C, Friehs I, Mayer JE Jr, Zurakowski D, Triedman JK, Moran AM, Walsh EP, Lock JE, Jonas RA, Del Nido PJ. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001; 121: 28–41.[CrossRef][Medline] [Order article via Infotrieve]
14. Walsh EP, Rockenmacher S, Keane JF, Hougen TJ, Lock JE, Castaneda AR. Late results in patients with tetralogy of Fallot repaired during infancy. Circulation. 1988; 77: 1062–1067.
15. Anderson RH, Ho SY. The disposition of the conduction tissues in congenitally malformed hearts with reference to their embryological development. J Perinat Med. 1991; 19: 201–206.[Medline] [Order article via Infotrieve]
16. Attenhofer Jost CH, Connolly HM, Edwards WD, Hayes D, Warnes CA, Danielson GK. Ebstein’s anomaly: review of a multifaceted congenital cardiac condition. Swiss Med Wkly. 2005; 135: 269–281.[Medline] [Order article via Infotrieve]
17. Levine J, Walsh EP, Saul JP. Catheter ablation of accessory pathways in patients with congenital heart disease including heterotaxy syndrome. Am J Cardiol. 1993; 72: 689–694.[CrossRef][Medline] [Order article via Infotrieve]
18. Oh JK, Holmes DR Jr, Hayes DL, Porter CB, Danielson GK. Cardiac arrhythmias in patients with surgical repair of Ebstein’s anomaly. J Am Coll Cardiol. 1985; 6: 1351–1357.[Abstract]
19. Smith WM, Gallagher JJ, Kerr CR, Sealy WC, Kasell JH, Benson DW, Reiter MJ, Sterba R, Grant AO. The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol. 1982; 49: 1223–1234.[CrossRef][Medline] [Order article via Infotrieve]
20. Reich JD, Auld D, Hulse E, Sullivan K, Campbell R; Pediatric Electrophysiology Society. The Pediatric Radiofrequency Ablation Registry’s experience with Ebstein’s anomaly. J Cardiovasc Electrophysiol. 1998; 9: 1370–1377.[Medline] [Order article via Infotrieve]
21. Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004; 1: 168–173.[CrossRef][Medline] [Order article via Infotrieve]
22. Shah MJ, Jones TK, Cecchin F. Improved localization of right-sided accessory pathways with microcatheter-assisted right coronary artery mapping in children. J Cardiovasc Electrophysiol. 2004; 15: 1238–1243.[CrossRef][Medline] [Order article via Infotrieve]
23. Lev M, Licata RH, May RC. The conduction system in mixed levocardia with ventricular inversion (corrected transposition). Circulation. 1963; 28: 232–237.
24. Mönckeberg JG. Zur entwicklungsgeschichte des atrioventrikularsystems. Verh Deutsch Path Ges. 1913; 16: 228–249.
25. Epstein MR, Saul JP, Weindling SN, Triedman JK, Walsh EP. Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. J Cardiovasc Electrophysiol. 2001; 12: 671–679.[CrossRef][Medline] [Order article via Infotrieve]
26. Wu MH, Wang JK, Lin JL, Lai LP, Lue HC, Young ML, Hsieh FJ. Supraventricular tachycardia in patients with right atrial isomerism. J Am Coll Cardiol. 1998; 32: 773–779.
27. Ghai A, Harris L, Harrison DA, Webb GD, Siu SC. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol. 2001; 37: 585–592.
28. Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, Spector P, Calame JD, Rao A, Hasdemir C, Otomo K, Wang Z, Lazzara R, Jackman WM. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation. 2001; 103: 699–709.
29. Kalman JK, Van Hare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of "incisional" reentrant atrial tachycardia complicating surgery for congenital heart disease. Circulation. 1996; 93: 502–512.
30. Triedman JK, Jenkins KJ, Colan SD, Saul JP, Walsh EP. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997; 8: 259–270.[Medline] [Order article via Infotrieve]
31. Rhodes LA, Walsh EP, Gamble WJ, Triedman JK, Saul JP. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995; 18: 1005–1016.[CrossRef][Medline] [Order article via Infotrieve]
32. Li W, Somerville J. Atrial flutter in grown-up congenital heart (GUCH) patients: clinical characteristics of affected population. Int J Cardiol. 2000; 75: 129–137.[CrossRef][Medline] [Order article via Infotrieve]
33. Wong T, Davlouros PA, Li W, Millington-Sanders C, Francis DP, Gatzoulis MA. Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation. 2004; 109: 2319–2325.
34. Collins KK, Love BA, Walsh EP, Saul JP, Epstein MR, Triedman JK. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000; 86: 969–974.[CrossRef][Medline] [Order article via Infotrieve]
35. Triedman JK, Alexander ME, Berul CI, Bevilacqua LM, Walsh EP. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001; 103: 2060–2065.
36. Mandapati R, Walsh EP, Triedman JK. Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003; 14: 119–112.[Medline] [Order article via Infotrieve]
37. Delacretaz E, Ganz LI, Friedman PL, Walsh EP, Triedman JK, Sloss LJ, Landzberg MJ, Stevenson WG. Multiple atrial macroreentry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001; 37: 1665–1676.
38. Rhodes LA, Walsh EP, Saul JP. Conversion of atrial flutter in pediatric patients using transesophageal atrial pacing: a safe, effective, and minimally invasive technique. Am Heart J. 1995; 130: 323–327.[CrossRef][Medline] [Order article via Infotrieve]
39. Triedman JK. Atrial reentrant tachycardias. In: Walsh EP, Saul JP, Triedman JK, eds. Cardiac Arrhythmias in Children and Young Adults With Congenital Heart Disease. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001: 137–160.
40. Stevenson EA, Casavant D, Tuzi J, Alexander MA, Law I, Serwer G, Strieper M, Walsh EP, Berul CI. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol. 2003; 92: 871–876.[CrossRef][Medline] [Order article via Infotrieve]
41. Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997; 30: 1032–1038.[Abstract]
42. Triedman JK, Alexander MA, Love BA, Collins KK, Berul CI, Bevilacqua LM, Walsh EP. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002; 39: 1827–1835.
43. Jais P, Shah DC, Haissaguerre M, Hocini M, Garrigue S, Le Metayer P, Clementy J. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation. 2000; 101: 772–776.
44. Triedman JK, Delucca JM, Alexander ME, Berul CI, Cecchin F, Walsh EP. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005; 2: 700–705.[CrossRef][Medline] [Order article via Infotrieve]
45. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001; 122: 863–871.
46. Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intraatrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002; 90: 338–340.[CrossRef][Medline] [Order article via Infotrieve]
47. Deal BJ, Mavroudis C, Backer CL Beyond Fontan conversion: surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg. 2003; 76: 542–553.
48. Horowitz LN, Vetter VL, Harken AH, Josephson ME. Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of Fallot. Am J Cardiol. 1980; 46: 446–452.[CrossRef][Medline] [Order article via Infotrieve]
49. Downar E, Harris L, Kimber S, Mickleborough L, Williams W, Sevaptsidis E, Masse S, Chen TC, Chan A, Genga A. Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies. J Am Coll Cardiol. 1992; 20: 648–655.[Abstract]
50. Wolfe RR, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, Kidd L, O’Fallon WM, Pieroni DR, Weidman WH. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect: results of 24-hour ECG monitoring. Circulation. 1993; 87 (suppl): I-89–I-101.[Medline] [Order article via Infotrieve]
51. Keane JF, Driscoll DJ, Gersony WM, Hayes CJ, Kidd L, O’Fallon WM, Pieroni DR, Wolfe RR, Weidman WH. Second natural history study of congenital heart defects: results of treatment of patients with aortic valvar stenosis. Circulation. 1993; 87 (suppl): I-16–I-27.[Medline] [Order article via Infotrieve]
52. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart. 2000; 84: 409–415.
53. Deanfield JE, McKenna WJ, Presbitero P, England D, Graham GR, Hallidie-Smith K. Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot: relation to age, timing of repair, and haemodynamic status. Br Heart J. 1984; 52: 77–81.
54. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995; 92: 231–237.
55. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000; 356: 975–981.[CrossRef][Medline] [Order article via Infotrieve]
56. Berul CI, Hill SL, Geggel RL, Hijazi ZM, Marx GR, Rhodes J, Walsh KA, Fulton DR. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol. 1997; 8: 1349–1356.[Medline] [Order article via Infotrieve]
57. Wolff GS, Rowland TW, Ellison RC. Surgically induced right bundle-branch block with left anterior hemiblock: an ominous sign in postoperative tetralogy of Fallot. Circulation. 1972; 46: 587–594.
58. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997; 30: 1374–1383.[Abstract]
59. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998; 32: 245–251.
60. Norgaard MA, Lauridsen P, Helvind M, Pettersson G. Twenty-to-thirty-seven-year follow-up after repair for Tetralogy of Fallot. Eur J Cardiothorac Surg. 1999; 16: 125–130.
61. Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot: electrocardiographic and electrophysiologic abnormalities. Circulation. 1977; 56: 566–571.
62. Garson A Jr, Nihill MR, McNamara DG, Cooley DA. Status of the adult and adolescent after repair of tetralogy of Fallot. Circulation. 1979; 59: 1232–1240.
63. Deanfield JE, Ho SY, Anderson RH, McKenna WJ, Allwork SP, Hallidie-Smith KA. Late sudden death after repair of tetralogy of Fallot: a clinicopathologic study. Circulation. 1983; 67: 626–631.
64. Garson A Jr, Porter CJ, Gillette PC, McNamara DG. Induction of ventricular tachycardia during electrophysiologic study after repair of tetralogy of Fallot. J Am Coll Cardiol. 1983; 1: 1493–1502.[Abstract]
65. Kugler JD, Pinsky WW, Cheatham JP, Hofschire PJ, Mooring PK, Fleming WH. Sustained ventricular tachycardia after repair of tetralogy of Fallot: new electrophysiologic findings. Am J Cardiol. 1983; 51: 1137–1143.[CrossRef][Medline] [Order article via Infotrieve]
66. Kavey RE, Thomas FD, Byrum CJ, Blackman MS, Sondheimer HM, Bove EL. Ventricular arrhythmias and biventricular dysfunction after repair of tetralogy of Fallot. J Am Coll Cardiol. 1984; 4: 126–131.[Abstract]
67. Dunnigan A, Pritzker MR, Benditt DG, Benson DW Jr. Life threatening ventricular tachycardias in late survivors of surgically corrected tetralogy of Fallot. Br Heart J. 1984; 52: 198–206.
68. Kobayashi J, Hirose H, Nakano S, Matsuda H, Shirakura R, Kawashima Y. Ambulatory electrocardiographic study of the frequency and cause of ventricular arrhythmia after correction of tetralogy of Fallot. Am J Cardiol. 1984; 54: 1310–1313.[CrossRef][Medline] [Order article via Infotrieve]
69. Burns RJ, Liu PP, Druck MN, Seawright SJ, Williams WG, McLaughlin PR. Analysis of adults with and without complex ventricular arrhythmias after repair of tetralogy of Fallot. J Am Coll Cardiol. 1984; 4: 226–233.[Abstract]
70. Garson A Jr, Randall DC, Gillette PC, Smith RT, Moak JP, McVey P, McNamara DG. Prevention of sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias. J Am Coll Cardiol. 1985; 6: 221–227.[Abstract]
71. Deal BJ, Scagliotti D, Miller SM, Gallastegui JL, Hariman RJ, Levitsky S. Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot. Am J Cardiol. 1987; 59: 1380–1385.[CrossRef][Medline] [Order article via Infotrieve]
72. Chandar JS, Wolff GS, Garson A Jr, Bell TJ, Beder SD, Bink-Boelkens M, Byrum CJ, Campbell RM, Deal BJ, Dick M, Flinn CJ, Guam WE, Gillette PC, Hordorf AJ, Kugler JD, Porter CJ, Walsh EP. Ventricular arrhythmia in post-operative tetralogy of Fallot. Am J Cardiol. 1990; 65: 655–661.[CrossRef][Medline] [Order article via Infotrieve]
73. Zimmermann M, Friedli B, Adamec R, Oberhansli I. Ventricular late potentials and induced ventricular arrhythmias after surgical repair of tetralogy of Fallot. Am J Cardiol. 1991; 67: 873–878.[CrossRef][Medline] [Order article via Infotrieve]
74. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J Am Coll Cardiol. 1994; 23: 1151–1155.[Abstract]
75. Jonsson H, Ivert T, Brodin LA, Jonasson R. Late sudden deaths after repair of tetralogy of Fallot: electrocardiographic findings associated with survival. Scand J Thorac Cardiovasc Surg. 1995; 29: 131–139.[Medline] [Order article via Infotrieve]
76. Balaji S, Lau YR, Case CL, Gillette PC. QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot. Am J Cardiol. 1997; 80: 160–163.[CrossRef][Medline] [Order article via Infotrieve]
77. Daliento L, Rizzoli G, Menti L, Baratella MC, Turrini P, Nava A, Dalla Volta S. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart. 1999; 81: 650–655.
78. Lucron H, Marcon F, Bosser G, Lethor JP, Marie PY, Brembilla-Perrot B. Induction of sustained ventricular tachycardia after surgical repair of tetralogy of Fallot. Am J Cardiol. 1999; 83: 1369–1373.[CrossRef][Medline] [Order article via Infotrieve]
79. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, Williams WG, Webb G, Gatzoulis MA. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001; 103: 2489–2494.
80. Hamada H, Terai M, Jibiki T, Nakamura T, Gatzoulis MA, Niwa K. Influence of early repair of tetralogy of Fallot without an outflow patch on late arrhythmias and sudden death: a 27-year follow-up study following a uniform surgical approach. Cardiol Young. 2002; 12: 345–351.[Medline] [Order article via Infotrieve]
81. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002; 40: 1675–1680.
82. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center experience. Pacing Clin Electrophysiol. 2004; 27: 47–51.[CrossRef][Medline] [Order article via Infotrieve]
83. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marçon F, Walsh EP. Prognostic significance of electrophysiologic testing post tetralogy of Fallot repair: a multicenter study. Circulation. 2004; 109: 1994–2000.
84. Russo G, Folino AF, Mazzotti E, Rebellato L, Daliento L. Comparison between QRS duration at standard ECG and signal-averaging ECG for arrhythmic risk stratification after surgical repair of tetralogy of Fallot. J Cardiovasc Electrophysiol. 2005; 16: 288–292.[CrossRef][Medline] [Order article via Infotrieve]
85. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999; 10: 1033–1044.[Medline] [Order article via Infotrieve]
86. Goldner BG, Cooper R, Blau W, Cohen TJ. Radiofrequency catheter ablation as a primary therapy for treatment of ventricular tachycardia in a patient after repair of tetralogy of Fallot. Pacing Clin Electrophysiol. 1994; 17: 1441–1446.[CrossRef][Medline] [Order article via Infotrieve]
87. Burton ME, Leon AR. Radiofrequency catheter ablation of right ventricular outflow tract tachycardia late after complete repair of tetralogy of Fallot using the pace mapping technique. Pacing Clin Electrophysiol. 1993; 16: 2319–2325.[CrossRef][Medline] [Order article via Infotrieve]
88. Gonska BD, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation. 1996; 94: 1902–1908.
89. Morwood JG, Triedman JK, Berul CI, Khairy P, Alexander ME, Cecchin F, Walsh EP. Radiofrequency catheter ablation of ventricular tachycardia in children, and in young adults with congenital heart disease. Heart Rhythm. 2004; 1: 301–308.[CrossRef][Medline] [Order article via Infotrieve]
90. Mullen MP, VanPraagh R, Walsh EP. Development and anatomy of the cardiac conduction system. In: Walsh EP, Saul JP, Triedman JK, eds. Cardiac Arrhythmias in Children and Young Adults With Congenital Heart Disease. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001: 93–111.
91. Manning PB, Mayer JE, Wernovsky G, Fishberger SB, Walsh EP. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996; 111: 833–840.
92. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol. 2002; 40: 1703–1719.
93. VanPraagh R, Papagiannis J, Grunenfelder J, Bartram U, Martanovic P. Pathologic anatomy of corrected transposition of the great arteries: medical and surgical implications. Am Heart J. 1998; 135: 772–785.[CrossRef][Medline] [Order article via Infotrieve]
94. Anderson RH, Becker AE, Arnold R, Wilkinson JL. The conducting tissues in congenitally corrected transposition. Circulation. 1974; 50: 911–923.
95. Thiene G, Wenick ACG, Frescura C, Wilkinson JL, Gallucci V, Ho SY, Mazzucco A, Anderson RH. Surgical anatomy and pathology of the conduction tissues in atrioventricular defects. J Thorac Cardiovasc Surg. 1981; 82: 928–937.[Medline] [Order article via Infotrieve]
96. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation. 1983; 67: 1374–1377.
97. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol. 1996; 27: 1238–1243.[Abstract]
98. Dick M, Norwood WI, Chipman C, Castaneda AR. Intraoperative recording of specialized atrioventricular conduction tissue electrograms in 47 patients. Circulation. 1979; 59: 150–160.
99. Cohen MI, Rhodes LA, Spray TL, Gaynor JW. Efficacy of prophylactic epicardial pacing leads in children and young adults. Ann Thorac Surg. 2004; 1: 197–202.
100. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center experience. Pacing Clin Electrophysiol. 2004; 1: 47–51.
101. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Al Ahmad A, Vetter VL, Kertesz NJ, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani S, Kanter R, Batra A, Collins KK. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005; 46: 2277–2283.
102. Minniti S, Visentini S, Procacci C. Congenital anomalies of the vena cavae: embryological origin, imaging features and report of three new variants. Eur Radiol. 2002; 8: 2040–2055.
103. Ratliff HL, Yousufuddin M, Lieving WR, Watson BE, Malas A, Rosencrance G, McCowan RJ. Persistent left superior vena cava: case reports and clinical implications. Int J Cardiol. 2006; 113: 242–246.[CrossRef][Medline] [Order article via Infotrieve]
104. Khairy P, Triedman JK, Juraszek A, Cecchin F. Inability to cannulate the coronary sinus in patients with supraventricular arrhythmias: congenital and acquired coronary sinus atresia. J Interv Card Electrophysiol. 2005; 2: 123–127.[Medline] [Order article via Infotrieve]
105. Spittell PC, Hayes DL. Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc. 1992; 67: 258–265.[Medline] [Order article via Infotrieve]
106. Bracke F, Meijer A, van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: influence of patient and lead characteristics. Pacing Clin Electrophysiol. 2003; 26: 1649–1652.[CrossRef][Medline] [Order article via Infotrieve]
107. van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol. 2004; 15: 1258–1262.[CrossRef][Medline] [Order article via Infotrieve]
108. McCotter CJ, Angle JF, Prudente LA, Mounsey JP, Ferguson JD, DiMarco JP, Hummel JP, Mangrum JM. Placement of transvenous pacemaker and ICD leads across total chronic occlusions. Pacing Clin Electrophysiol. 2005; 28: 921–925.[CrossRef][Medline] [Order article via Infotrieve]
109. Shah MJ, Nehgme R, Carboni M, Murphy JD. Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the Fontan procedure. Pacing Clin Electrophysiol. 2004; 27: 949–954.[CrossRef][Medline] [Order article via Infotrieve]
110. Hansky B, Blanz U, Peuster M, Gueldner H, Sandica E, Crespo-Martinez E, Mathies W, Meyer H, Koerfer R. Endocardial pacing after Fontan-type procedures. Pacing Clin Electrophysiol. 2005; 28: 140–148.[CrossRef][Medline] [Order article via Infotrieve]
111. Adwani SS, Sreeram N, DeGiovanni JV. Percutaneous transhepatic dual chamber pacing in children with Fontan circulation. Heart. 1997; 77: 574–575.
112. Ermis C, Zadeii G, Gupta M, Benditt DG. Trans-aortic His bundle ablation with permanent ventricular pacing via the coronary sinus in L-transposition of great arteries with classic Fontan procedure. J Interv Card Electrophysiol. 2002; 3: 257–260.
113. Khairy P, Landzberg MJ, Lambert J, O’Donnell CP. Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures. Cardiol Young. 2004; 14: 284–292.[CrossRef][Medline] [Order article via Infotrieve]
114. Van Gelder BM, Bracke FA, Oto A, Yildirir A, Haas PC, Seger JJ, Stainback RF, Botman KJ, Meijer A. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature. Pacing Clin Electrophysiol. 2000; 23: 877–883.[CrossRef][Medline] [Order article via Infotrieve]
115. Weber HS. Incidence and predictors for the development of significant supradiaphragmatic decompressing venous collateral channels following creation of Fontan physiology. Cardiol Young. 2001; 11: 289–294.[CrossRef][Medline] [Order article via Infotrieve]
116. Sugiyama H, Yoo SJ, Williams W, Benson LN. Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation. Cardiol Young. 2003; 13: 424–430.[Medline] [Order article via Infotrieve]
117. Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, Rome JJ, Hellenbrand WE, Ruiz CE, Jenkins KJ. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004; 110: 501–507.
118. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003; 139: 753–760.
119. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006; 17: 41–46.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  A. Giardini, A. Hager, A. E. Lammers, G. Derrick, J. Muller, G.-P. Diller, K. Dimopoulos, D. Odendaal, G. Gargiulo, F. M. Picchio, et al. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1548 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
|
|
F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure Circulation, April 1, 2008; 117(13): 1717 - 1731. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bedard, D. F. Shore, and M. A. Gatzoulis Adult congenital heart disease: a 2008 overview Br. Med. Bull., March 1, 2008; 85(1): 151 - 180. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||